WHO To Resume Hydroxychloroquine’s Trial On 3500 Corona Patients
New Delhi: The World Health Organization (WHO) has decided to resume the clinical trials of anti-malarial drug Hydroxychloroquine for treating COVID-19 patients. The initial trials will be conducted on over ...
